The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
Oxidative stress injury in doxorubicin-induced cardiotoxicity
Abstract
Doxorubicin (DOX) is widely used as a broad-spectrum anti-tumor anthracycline to treat various cancers. The serious adverse effects of DOX on cardiotoxicity limit its clinical application. There are several different mechanisms involved in DOX-induced cardiotoxicity. Oxidative stress (OS) is caused by an imbalance between reactive oxygen species (ROS) and endogenous antioxidants in response to injury, which can lead to myocardial toxicity. The aim of this review was to investigate the mechanisms underlying the effects of oxidative stress injury on myocardial toxicity, from three different aspects: the increase in downstream oxidative stress products, the reduction in upstream antioxidative stress products, and subcellular organelles. Finally, there are some anti-oxidative drugs that show efficacy in limiting DOX-induced cardiotoxicity. It is necessary to fully understand the toxicity of DOX to the myocardium and achieve symptomatic treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21442 · Cited by 16,579
The Unfolded Protein Response: From Stress Pathway to Homeostatic Regulation
Walter, P., & Ron, D. (2011) · Science · doi:10.1126/science.1209038 · Cited by 5,924
The unfolded protein response: controlling cell fate decisions under ER stress and beyond
Hetz, C. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3270 · Cited by 4,093
Yoshida, H., Matsui, T., Yamamoto, A., Okada, T., & Mori, K. (2001) · Cell · doi:10.1016/s0092-8674(01)00611-0 · Cited by 4,039
Reactive oxygen species in cancer
Liou, G.-Y., & Storz, P. (2010) · Free Radical Research · doi:10.3109/10715761003667554 · Cited by 3,382
Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress
Tabas, I., & Ron, D. (2011) · Nature Cell Biology · doi:10.1038/ncb0311-184 · Cited by 2,598
Identification of the molecular basis of doxorubicin-induced cardiotoxicity
Zhang, S., Liu, X., Bawa-Khalfe, T., Lu, L.-S., Lyu, Y. L., Liu, L. F., & Yeh, E. T. H. (2012) · Nature Medicine · doi:10.1038/nm.2919 · Cited by 1,948
Omega-3 Fatty Acids and Cardiovascular Disease
Mozaffarian, D., & Wu, J. H. Y. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.06.063 · Cited by 1,771
Moi, P., Chan, K., Asunis, I., Cao, A., & Kan, Y. W. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9926 · Cited by 1,607
Endoplasmic Reticulum Stress and Oxidative Stress: A Vicious Cycle or a Double-Edged Sword?
Malhotra, J. D., & Kaufman, R. J. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1782 · Cited by 1,563
A clinicopathologic analysis of adriamycin cardiotoxicity
Lefrak, E. A., Piťha, J., Rosenheim, S., & Gottlieb, J. A. (1973) · Cancer · doi:10.1002/1097-0142(197308)32:2<302::aid-cncr2820320205>3.0.co;2-2 · Cited by 1,560
Adriamycin-Induced DNA Damage Mediated by Mammalian DNA Topoisomerase II
Tewey, K. M., Rowe, T. C., Yang, L., Halligan, B. D., & Liu, L. F. (1984) · Science · doi:10.1126/science.6093249 · Cited by 1,538
Doxorubicin: The good, the bad and the ugly effect
Carvalho, C., Santos, R., Cardoso, S., Correia, S., Oliveira, P., Santos, M., & Moreira, P. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709788803312 · Cited by 1,509
The role of iron regulatory proteins in mammalian iron homeostasis and disease
Rouault, T. A. (2006) · Nature Chemical Biology · doi:10.1038/nchembio807 · Cited by 1,055
Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation
Ichikawa, Y., Ghanefar, M., Bayeva, M., Wu, R., Khechaduri, A., Prasad, S. V. N., Mutharasan, R. K., Naik, T. J., & Ardehali, H. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72931 · Cited by 878
Šimůnek, T., Štěrba, M., Popelová, O., Adamcová, M., Hrdina, R., & Geršl, V. (2009) · Pharmacological Reports · doi:10.1016/s1734-1140(09)70018-0 · Cited by 769
Modifiable Risk Factors and Major Cardiac Events Among Adult Survivors of Childhood Cancer
Armstrong, G. T., Oeffinger, K. C., Chen, Y., Kawashima, T., Yasui, Y., Leisenring, W., Stovall, M., Chow, E. J., Sklar, C. A., Mulrooney, D. A., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.49.3205 · Cited by 734
Cardiotoxicity of Chemotherapeutic Agents: Incidence, Treatment and Prevention
Pai, V. B., & Nahata, M. C. (2000) · Drug Safety · doi:10.2165/00002018-200022040-00002 · Cited by 729
Protective Effects of Carvedilol Against Anthracycline-Induced Cardiomyopathy
Kalay, N., Basar, E., Ozdogru, I., Er, O., Cetinkaya, Y., Dogan, A., Oguzhan, A., Eryol, N. K., Topsakal, R., Ergin, A., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.052 · Cited by 713
Davies, K. J., & Doroshow, J. H. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35746-0 · Cited by 631
NADPH Oxidases in Cardiovascular Health and Disease
Cave, A. C., Brewer, A. C., Narayanapanicker, A., Ray, R., Grieve, D. J., Walker, S., & Shah, A. M. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.691 · Cited by 630
Metabolic Syndrome, Aging and Involvement of Oxidative Stress
Bonomini, F., Rodella, L. F., & Rezzani, R. (2015) · Aging and Disease · doi:10.14336/ad.2014.0305 · Cited by 599
Diabetic hyperglycaemia activates CaMKII and arrhythmias by O-linked glycosylation
Erickson, J. R., Pereira, L., Wang, L., Han, G., Ferguson, A., Dao, K., Copeland, R. J., Despa, F., Hart, G. W., Ripplinger, C. M., et al. (2013) · Nature · doi:10.1038/nature12537 · Cited by 598
Role of Reactive Oxygen Species in the Progression of Type 2 Diabetes and Atherosclerosis
Kaneto, H., Katakami, N., Matsuhisa, M., & Matsuoka, T.-A. (2010) · Mediators of Inflammation · doi:10.1155/2010/453892 · Cited by 575
Enzymic and non-enzymic antioxidants in epidermis and dermis of human skin
Shindo, Y., Witt, E., Han, D., Epstein, W., & Packer, L. (1994) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12371744 · Cited by 546
Byrne, *., Grieve, D. J., Bendall, J. K., Li, J.-M., Gove, C., Lambeth, J. D., Cave, A. C., & Shah, A. M. (2003) · Circulation Research · doi:10.1161/01.res.0000099504.30207.f5 · Cited by 411
Endothelial Nitric Oxide Synthase-Dependent Superoxide Generation from Adriamycin
Vásquez-Vivar, J., Martasek, P., Hogg, N., Masters, B. S. S., Pritchard, & Kalyanaraman, B. (1997) · Biochemistry · doi:10.1021/bi971475e · Cited by 366
Antoniades, C., Shirodaria, C., Warrick, N., Cai, S., de Bono, J., Lee, J., Leeson, P., Neubauer, S., Ratnatunga, C., Pillai, R., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.612325 · Cited by 365
Keap1–Nrf2 Signaling: A Target for Cancer Prevention by Sulforaphane
Kensler, T. W., Egner, P. A., Agyeman, A. S., Visvanathan, K., Groopman, J. D., Chen, J.-G., Chen, T.-Y., Fahey, J. W., & Talalay, P. (2012) · Topics in Current Chemistry · doi:10.1007/128_2012_339 · Cited by 361
Cappetta, D., De Angelis, A., Sapio, L., Prezioso, L., Illiano, M., Quaini, F., Rossi, F., Berrino, L., Naviglio, S., & Urbanek, K. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/1521020 · Cited by 350
Seicean, S., Seicean, A., Plana, J. C., Budd, G. T., & Marwick, T. H. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.07.067 · Cited by 326
Regula, K. M., Ens, K., & Kirshenbaum, L. A. (2002) · Circulation Research · doi:10.1161/01.res.0000029232.42227.16 · Cited by 318
Nix and Nip3 Form a Subfamily of Pro-apoptotic Mitochondrial Proteins
Chen, G., Cizeau, J., Vande Velde, C., Park, J. H., Bozek, G., Bolton, J., Shi, L., Dubik, D., & Greenberg, A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.1.7 · Cited by 310
Spallarossa, P., Garibaldi, S., Altieri, P., Fabbi, P., Manca, V., Nasti, S., Rossettin, P., Ghigliotti, G., Ballestrero, A., & Patrone, F. (2004) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2004.05.024 · Cited by 294
Diabetic neuropathy and oxidative stress
Pop-Busui, R., Sima, A., & Stevens, M. (2006) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.625 · Cited by 286
Gao, L., Wang, J., Sekhar, K. R., Yin, H., Yared, N. F., Schneider, S. N., Sasi, S., Dalton, T. P., Anderson, M. E., Chan, J. Y., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607622200 · Cited by 277
Bougnoux, P., Hajjaji, N., Ferrasson, M. N., Giraudeau, B., Couet, C., & Le Floch, O. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605441 · Cited by 264
Capranico, G., Tinelli, S., Austin, C. A., Fisher, M. L., & Zunino, F. (1992) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(92)90050-a · Cited by 258
Efficiency of Atorvastatin in the Protection of Anthracycline-Induced Cardiomyopathy
Acar, Z., Kale, A., Turgut, M., Demircan, S., Durna, K., Demir, S., Meriç, M., & Ağaç, M. T. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.05.025 · Cited by 255
Pathways of cardiac toxicity: comparison between chemotherapeutic drugs doxorubicin and mitoxantrone
Damiani, R. M., Moura, D. J., Viau, C. M., Caceres, R. A., Henriques, J. A. P., & Saffi, J. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1759-y · Cited by 247
Nox2 NADPH Oxidase Promotes Pathologic Cardiac Remodeling Associated with Doxorubicin Chemotherapy
Zhao, Y., McLaughlin, D., Robinson, E., Harvey, A. P., Hookham, M. B., Shah, A. M., McDermott, B. J., & Grieve, D. J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2664 · Cited by 244
Diabetes increases mortality after myocardial infarction by oxidizing CaMKII
Luo, M., Guan, X., Luczak, E. D., Lang, D., Kutschke, W., Gao, Z., Yang, J., Glynn, P., Sossalla, S., Swaminathan, P. D., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65268 · Cited by 240
Minotti, G., Ronchi, R., Salvatorelli, E., Menna, P., & Cairo, G. (2001) · PubMed · Cited by 227
Yasuda, M., Theodorakis, P., Subramanian, T., & Chinnadurai, G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.20.12415 · Cited by 218
Dhingra, R., Margulets, V., Chowdhury, S. R., Thliveris, J., Jassal, D., Fernyhough, P., Dorn, G. W., & Kirshenbaum, L. A. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1414665111 · Cited by 217
The role of Bcl-2 family member BNIP3 in cell death and disease: NIPping at the heels of cell death
Burton, T. R., & Gibson, S. B. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2008.185 · Cited by 216
Introducing a new entity: chemotherapy-induced arrhythmia
Guglin, M., Aljayeh, M., Saiyad, S., Ali, R., & Curtis, A. B. (2009) · Europace · doi:10.1093/europace/eup300 · Cited by 214
Small molecule modulators of antioxidant response pathway
Hur, W., & Gray, N. S. (2011) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2010.12.009 · Cited by 211
Pretreatment with Statin Attenuates the Cardiotoxicity of Doxorubicin in Mice
Riad, A., Bien, S., Westermann, D., Becher, P. M., Loya, K., Landmesser, U., Kroemer, H. K., Schultheiss, H. P., & Tschöpe, C. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3076 · Cited by 205
Zhao, L., Tao, X., Qi, Y., Xu, L., Yin, L., & Peng, J. (2018) · Redox Biology · doi:10.1016/j.redox.2018.02.026 · Cited by 202
Nrf2 Deficiency Exaggerates Doxorubicin-Induced Cardiotoxicity and Cardiac Dysfunction
Li, S., Wang, W., Niu, T., Wang, H., Li, B., Shao, L., Lai, Y., Li, H., Janicki, J. S., Wang, X. L., et al. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/748524 · Cited by 183
Cardioprotective mechanisms of phytochemicals against doxorubicin-induced cardiotoxicity
Abushouk, A. I., Ismail, A., Salem, A. M. A., Afifi, A. M., & Abdel-Daim, M. M. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.04.033 · Cited by 182
Fan, G.-C., Zhou, X., Wang, X., Song, G., Qian, J., Nicolaou, P., Chen, G., Ren, X., & Kranias, E. G. (2008) · Circulation Research · doi:10.1161/circresaha.108.182832 · Cited by 178
GOFFART, S., VONKLEISTRETZOW, J., & WIESNER, R. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.06.030 · Cited by 176
Carvedilol Protects against Doxorubicin-Induced Mitochondrial Cardiomyopathy
Santos, D. (2002) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2002.9532 · Cited by 174
Tissue-protective effects of fullerenol C60(OH)24 and amifostine in irradiated rats
Trajković, S., Dobrić, S., Jaćević, V., Dragojević-Simić, V., Milovanović, Z., & Đorđević, A. (2007) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2007.01.005 · Cited by 168
Neilan, T. G., Blake, S. L., Ichinose, F., Raher, M. J., Buys, E. S., Jassal, D. S., Furutani, E., Perez-Sanz, T. M., Graveline, A., Janssens, S. P., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.652339 · Cited by 167
Goormaghtigh, E., Chatelain, P., Caspers, J., & Ruysschaert, J. (1980) · Biochemical Pharmacology · doi:10.1016/0006-2952(80)90050-7 · Cited by 166
Coenzyme Q10 for Prevention of Anthracycline-Induced Cardiotoxicity
Conklin, K. A. (2005) · Integrative Cancer Therapies · doi:10.1177/1534735405276191 · Cited by 165
TheGpx1Gene Encodes Mitochondrial Glutathione Peroxidase in the Mouse Liver
Esworthy, R. S., Ho, Y.-S., & Chu, F.-F. (1997) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1997.9901 · Cited by 164
Abdel-Daim, M. M., kilany, O. E., Khalifa, H. A., & Ahmed, A. A. M. (2017) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-017-3413-7 · Cited by 162
Recent progress in doxorubicin-induced cardiotoxicity and protective potential of natural products
Yu, J. Z., Wang, C., Kong, Q., Wu, X., Lu, J., & Chen, X. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.01.009 · Cited by 153
Sahu, B. D., Kumar, J. M., Kuncha, M., Borkar, R. M., Srinivas, R., & Sistla, R. (2015) · Life Sciences · doi:10.1016/j.lfs.2015.11.018 · Cited by 141
Sulforaphane protects the heart from doxorubicin-induced toxicity
Singh, P., Sharma, R., McElhanon, K. E., Allen, C. D., Megyesi, J. K., Beneš, H., & Singh, S. P. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.05.028 · Cited by 135
Mitochondrial DNA is a direct target of anti-cancer anthracycline drugs
Ashley, N., & Poulton, J. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.11.059 · Cited by 134
Dolinsky, V. W., Rogan, K. J., Sung, M. M., Zordoky, B. N., Haykowsky, M. J., Young, M. E., Jones, L. W., & Dyck, J. R. B. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00044.2013 · Cited by 133
Gutteridge, J. M. C. (1984) · Biochemical Pharmacology · doi:10.1016/0006-2952(84)90340-x · Cited by 133
Davies, K. J. A., Doroshow, J. H., & Hochstein, P. E. (1983) · FEBS Letters · doi:10.1016/0014-5793(83)80153-7 · Cited by 132
Jones, R. L., Swanton, C., & Ewer, M. S. (2006) · Expert Opinion on Drug Safety · doi:10.1517/14740338.5.6.791 · Cited by 132
Visualization of doxorubicin-induced oxidative stress in isolated cardiac myocytes
Sarvazyan, N. A. (1996) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1996.271.5.h2079 · Cited by 127
Chemical Endoplasmic Reticulum Chaperone Alleviates Doxorubicin-Induced Cardiac Dysfunction
Fu, H. Y., Sanada, S., Matsuzaki, T., Liao, Y., Okuda, K., Yamato, M., Tsuchida, S., Araki, R., Asano, Y., Asanuma, H., et al. (2016) · Circulation Research · doi:10.1161/circresaha.115.307604 · Cited by 126
El‐Agamy, D. S., El-Harbi, K. M., Khoshhal, S., Ahmed, N., Elkablawy, M. A., Shaaban, A. A., & Abo‐Haded, H. M. (2018) · Cancer Management and Research · doi:10.2147/cmar.s186696 · Cited by 125
Simvastatin Attenuates Oxidant-Induced Mitochondrial Dysfunction in Cardiac Myocytes
Jones, S. P., Teshima, Y., Akao, M., & Marbán, E. (2003) · Circulation Research · doi:10.1161/01.res.0000097262.21507.df · Cited by 124
Caroni, P., Villani, F., & Carafoli, E. (1981) · FEBS Letters · doi:10.1016/0014-5793(81)81115-5 · Cited by 123
Tsuneki, H., Sekizaki, N., Suzuki, T., Kobayashi, S., Wada, T., Okamoto, T., Kimura, I., & Sasaoka, T. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.03.006 · Cited by 116
Anthracycline-Induced Cardiotoxicity
Hrdina, R., Geršl, V., Klimtová, I., Šimůnek, T., Macháčková, J., & Adamcová, M. (2000) · Acta Medica (Hradec Kralove Czech Republic) · doi:10.14712/18059694.2019.117 · Cited by 110
Parker, M. A., King, V., & Howard, K. P. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(01)00371-6 · Cited by 107
Protective effects of carvedilol against doxorubicin-induced cardiomyopathy in rats
Matsui, H., Morishima, I., Numaguchi, Y., Toki, Y., Okumura, K., & Hayakawa, T. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00362-8 · Cited by 103
Hajra, S., Patra, A. R., Basu, A., et al. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.02.088 · Cited by 102
Sangomla, S., Saifi, M. A., Khurana, A., & Godugu, C. (2018) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2018.01.016 · Cited by 93
The interaction of adriamycin with cardiolipin in model and rat liver mitochondrial membranes
Nicolay, K., Timmers, R. J. M., Spoelstra, E. C., van der Neut, R., Fok, J. J., Huigen, Y. M., Verkleij, A. J., & KRUIJFF, B. D. (1984) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(84)90380-8 · Cited by 86
Kwok, J., & Richardson, D. R. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.4.849 · Cited by 82
Shaw, J., Zhang, T., Rzeszutek, M., Yurkova, N., Baetz, D., Davie, J., & Kirshenbaum, L. A. (2006) · Circulation Research · doi:10.1161/01.res.0000251744.06138.50 · Cited by 78
Effects of Oxidative Stress on Protein Translation: Implications for Cardiovascular Diseases
Ghosh, A., & Shcherbik, N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082661 · Cited by 77
Preventive Effects of Ellagic Acid Against Doxorubicin-Induced Cardio-Toxicity in Mice
Lin, M., & Yin, M. (2013) · Cardiovascular Toxicology · doi:10.1007/s12012-013-9197-z · Cited by 72
Cardiomyocyte autophagy and cancer chemotherapy
Li, D. ‘., & Hill, J. A. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.11.007 · Cited by 69
Chen, X., Peng, X., Luo, Y., You, J., Yin, D., Xu, Q., He, H., & He, M. (2019) · Toxicology Mechanisms and Methods · doi:10.1080/15376516.2018.1564948 · Cited by 69
Pathogenesis and prevention of doxorubicin cardiomyopathy.
Ferrans, V. J., Clark, J., Zhang, J., Yu, Z., & Herman, E. (1997) · PubMed · Cited by 68
Interaction of anthracyclines with iron responsive element mRNAs
Canzoneri, J. C., & Oyelere, A. K. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn774 · Cited by 67
Protective effect of Co‐enzyme Q10 On doxorubicin‐induced cardiomyopathy of rat hearts
Chen, P., Hou, C., Shibu, M. A., Day, C. H., Pai, P., Liu, Z., Lin, T., Viswanadha, V. P., Kuo, C., & Huang, C. (2016) · Environmental Toxicology · doi:10.1002/tox.22270 · Cited by 60
Kamble, S. M., & Patil, C. R. (2018) · Cardiovascular Toxicology · doi:10.1007/s12012-017-9424-0 · Cited by 59
Effects of Ganoderma lucidum polysaccharides against doxorubicin-induced cardiotoxicity
Xu, F., Li, X., Xiao, X., Liu, L.-F., Zhang, L., Lin, P.-P., Zhang, S., & Li, Q. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.08.118 · Cited by 57
Glutathione peroxidase 1-deficient mice are more susceptible to doxorubicin-induced cardiotoxicity
Gao, J., Xiong, Y., Ho, Y.-S., Liu, X., Chua, C. C., Xu, X., Wang, H., Hamdy, R. C., & Chua, B. H. L. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.05.027 · Cited by 54
Octavia, Y., Kararigas, G., de Boer, M., Chrifi, I., Kietadisorn, R., Swinnen, M., Duimel, H., Verheyen, F., Brandt, M. M., Fliegner, D., et al. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13231 · Cited by 53
Sunitha, M. C., Dhanyakrishnan, R., Prakashkumar, B., et al. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.03.089 · Cited by 52
Yoon, C. S., Kim, H. K., Mishchenko, N. P., Васильева, Е. А., Fedoreyev, S. A., Stonik, V. A., & Han, J. (2018) · Marine Drugs · doi:10.3390/md17010002 · Cited by 52
Teng, L., Shao, L., Yt, Z., Yu, X., Zhang, D., & Zhang, H. (2010) · Journal of International Medical Research · doi:10.1177/147323001003800320 · Cited by 41
Chen, J., He, P., Liu, Y.-H., Wei, X., Jiang, L., Guo, W., Duan, C., Guo, Y., Yu, X., Li, J., et al. (2018) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2018.5953 · Cited by 34
Eder, A. R., & Arriaga, E. A. (2006) · Chemical Research in Toxicology · doi:10.1021/tx060083i · Cited by 30
Kim, J. M., Ko, H., Kim, S., Shim, S. H., Ha, C. H., & Chang, H. I. (2015) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.21741 · Cited by 28
Interactions between doxorubicin and the human iron regulatory system
Brazzolotto, X., Andriollo-Sanchez, M., Guiraud, P., Favier, A. E., & Moulis, J. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(02)00391-9 · Cited by 27
Han, J., Wang, H., Zhang, T., Chen, Z., Zhao, T., Lin, L., Xia, G., & Wang, C. (2020) · Aging · doi:10.18632/aging.103061 · Cited by 27
Chen, C.-T., Wang, Z.-H., Hsu, C., Lin, H., & Chen, J. (2016) · Journal of Food and Drug Analysis · doi:10.1016/j.jfda.2016.09.002 · Cited by 26
Carbone, A., Psaltis, P. J., Nelson, A. J., Metcalf, R. G., Richardson, J. D., Weightman, M. J., Thomas, A., Finnie, J. W., Young, G. D., & Worthley, S. G. (2012) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2012.03.005 · Cited by 16
Cancer During Pregnancy: The Role of Vascular Toxicity in Chemotherapy-Induced Placental Toxicity
Bar‐Joseph, H., Peccatori, F. A., Goshen‐Lago, T., Cribiù, F. M., Scarfone, G., Miller, I., Nemerovsky, L., Levi, M., Shalgi, R., & Ben‐Aharon, I. (2020) · Cancers · doi:10.3390/cancers12051277 · Cited by 12
Cited by
Doxorubicin—An Agent with Multiple Mechanisms of Anticancer Activity
Kciuk, M., Gielecińska, A., Mujwar, S., Kołat, D., Kałuzińska-Kołat, Ż., Celik, I., & Kontek, R. (2023) · Cells · doi:10.3390/cells12040659 · Cited by 810
Amino acid metabolism in health and disease
Ling, Z.-N., Jiang, Y.-F., Ru, J.-N., Lu, J.-H., Ding, B., & Wu, J. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01569-3 · Cited by 545
New insights into the activities and toxicities of the old anticancer drug doxorubicin
van der Zanden, S. Y., Qiao, X., & Neefjes, J. (2021) · The FEBS Journal · doi:10.1111/febs.15583 · Cited by 410
Walkowski, B., Kleibert, M., Majka, M., & Wojciechowska, M. (2022) · Cells · doi:10.3390/cells11091553 · Cited by 117
Ismail, M. B., Rajendran, P., AbuZahra, H. M., & Veeraraghavan, V. P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084259 · Cited by 35
Metadata
- Authors
- Songbo, M., Lang, H., Xinyong, C., Bin, X., Ping, Z., & Liang, S.
- Venue
- Toxicology Letters
- Publisher
- Elsevier BV
- Published
- 2019-06
- Volume
- 307
- Pages
- 41-48
- ISSN
- 0378-4274 (ISSN-L)
- OpenAlex
- W2917210987
- Cited by
- 566
- References
- 105
- FWCI
- 36.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.